tumor

envie a um amigo share this

Regucalcin as a new tumor suppressor gene?

The research team of the Health Sciences Research Centre of the University of Beira Interior (CICS-UBI) led by Sílvia Socorro, together with other international researchers, has been publishing several studies aiming at clarifying the role of the calcium-binding protein Regucalcin (RGN) in the regulation of physiology (and pathophysiology) of various tissues and organs.

Rare Cells in Circulation: Circulating Tumor Cells and Other Tumor Products in the Circulation

Mount Holyoke College, South Hadley, MA, United States 

 

7 - 12 August, 2016

 

See more informations here: http://www.grc.org/programs.aspx?id=16786

Rare Cells in Circulation: Circulating Tumor Cells and Other Tumor Products in the Circulation

Mount Holyoke College, South Hadley, MA, United States 

 

7 - 12 August, 2016

 

See more informations here: http://www.grc.org/programs.aspx?id=16786

NAMPT and NAPRT1 mutations in normal tissues and tumor samples

In this work, mutations in NAMPT and NAPRT1 genes were identified in normal tissues and tumor samples. Some mutations presented different frequencies, which can be explained by the population of origin of the samples. Evaluation of the structural and functional impact of these mutations indicates that they can be relevant in a disease context.